Zoll® announced that transvenous phrenic nerve stimulation (TPNS) – the treatment currently available only by the ZOLL remedē System – is now included in the updated American Academy of Sleep Medicine (AASM) guidelines for treatment of central sleep apnea (CSA). The AASM recognizes the patient benefits of TPNS, highlighting the […]